JBIO dividend yield: 4.00%. ARCC dividend yield: 9.06%. JBIO is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in JBIO shares. Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
JBIO is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in JBIO shares.
Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
Is JBIO or ARCC better for dividend income in 2026?
JBIO currently offers a 4.00% yield (2.00/share/year) while ARCC offers 9.06% (1.92/share/year). ARCC provides higher current income. However, JBIO has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JBIO vs ARCC earn per year?
With $10,000 invested today: JBIO pays approximately $400/year. ARCC pays approximately $906/year. With DRIP reinvestment over 10 years, these grow to $899/year (JBIO) and $2,279/year (ARCC).
Does JBIO or ARCC pay monthly dividends?
JBIO pays quarterly dividends. ARCC pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JBIO vs ARCC comparison by email
Save your analysis + get weekly dividend insights. Free forever.